BCLI: Brainstorm Cell Therapeutics Inc. Stocks News on April 3, 2025

BCLI

GuruFocus.com

2 days ago

Brainstorm Cell Therapeutics Inc (BCLI) Q4 2024 Earnings Call Highlights: Navigating Financial ...

BCLI

Thomson Reuters StreetEvents

2 days ago

Q4 2024 Brainstorm Cell Therapeutics Inc Earnings Call

BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update

BCLI

PR Newswire

3 days ago

BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update

BrainStorm Cell Therapeutics Granted Compliance Extension from Nasdaq

BCLI

PR Newswire

8 days ago

BrainStorm Cell Therapeutics Granted Compliance Extension from Nasdaq

BrainStorm to Announce Fourth Quarter and Fiscal Year 2024 Financial Results and Provide a Corporate Update

BCLI

PR Newswire

10 days ago

BrainStorm to Announce Fourth Quarter and Fiscal Year 2024 Financial Results and Provide a Corporate Update

BCLI

Zacks Small Cap Research

3 months ago

BCLI: Plans Coming Together for Phase 3b Trial of NurOwn® in ALS…

BrainStorm Issues 2024 Letter to Shareholders

BCLI

PR Newswire

3 months ago

BrainStorm Issues 2024 Letter to Shareholders

BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update

BCLI

PR Newswire

4 months ago

BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update

BrainStorm Strengthens Exosome Patent Portfolio: Receives Notice of Allowance for U.S. Patent Covering Its Platform Technology

BCLI

PR Newswire

4 months ago

BrainStorm Strengthens Exosome Patent Portfolio: Receives Notice of Allowance for U.S. Patent Covering Its Platform Technology

BrainStorm Cell Therapeutics to Host KOL Webinar on Current Developments in the Treatment of Amyotrophic Lateral Sclerosis (ALS) on December 11, 2024

BCLI

PR Newswire

4 months ago

BrainStorm Cell Therapeutics to Host KOL Webinar on Current Developments in the Treatment of Amyotrophic Lateral Sclerosis (ALS) on December 11, 2024

BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

BCLI

PR Newswire

5 months ago

BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing

BCLI

PR Newswire

5 months ago

BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing

BrainStorm Cell Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

BCLI

PR Newswire

5 months ago

BrainStorm Cell Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

BrainStorm Cell Therapeutics Presented Positive Survival Data from NurOwn® Expanded Access Program at 2024 Annual NEALS Meeting

BCLI

PR Newswire

5 months ago

BrainStorm Cell Therapeutics Presented Positive Survival Data from NurOwn® Expanded Access Program at 2024 Annual NEALS Meeting

BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn® Trial at the 2024 Maxim Healthcare Virtual Summit

BCLI

PR Newswire

6 months ago

BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn® Trial at the 2024 Maxim Healthcare Virtual Summit

BrainStorm Cell Therapeutics Announces Presentations on NurOwn® at 2024 Annual NEALS Meeting

BCLI

PR Newswire

6 months ago

BrainStorm Cell Therapeutics Announces Presentations on NurOwn® at 2024 Annual NEALS Meeting

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

BCLI

GlobeNewswire

7 months ago

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

BCLI

Zacks Small Cap Research

7 months ago

BCLI: SPA in Place for Phase 3b Trial of NurOwn® in ALS…

BrainStorm Cell Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

BCLI

PR Newswire

8 months ago

BrainStorm Cell Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

BrainStorm Cell Therapeutics to Announce Second Quarter Results and Provide a Corporate Update

BCLI

PR Newswire

8 months ago

BrainStorm Cell Therapeutics to Announce Second Quarter Results and Provide a Corporate Update

BCLI

CNW Group

8 months ago

BCLI Update - Progress Supports Our 10x Plus Value Range Potential

BCLI

Zacks Small Cap Research

9 months ago

BCLI: Preparing to Initiate Phase 3b Trial of NurOwn™ Before End of 2024…

BrainStorm Cell Therapeutics to Provide Corporate Mid-Year Update on NurOwn Program

BCLI

PR Newswire

9 months ago

BrainStorm Cell Therapeutics to Provide Corporate Mid-Year Update on NurOwn Program

BCLI

MT Newswires

9 months ago

Brainstorm Cell Therapeutics Prices Registered Direct Offering, Concurrent Private Placement

BrainStorm Cell Therapeutics Announces Pricing of $4.0 Million Registered Direct Offering

BCLI

PR Newswire

9 months ago

BrainStorm Cell Therapeutics Announces Pricing of $4.0 Million Registered Direct Offering

BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn® Clinical Trial

BCLI

PR Newswire

9 months ago

BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn® Clinical Trial

BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer

BCLI

PR Newswire

9 months ago

BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer

BCLI

PR Newswire

10 months ago

BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness Expectation

Italian energy company targets Britain for fleet of 20 mini-nukes

BCLI

The Telegraph

10 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

BCLI

Motley Fool

10 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

BCLI

AFP

10 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

BCLI

Simply Wall St.

10 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

BCLI

Simply Wall St.

10 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

BCLI

Simply Wall St.

10 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

BCLI

Simply Wall St.

10 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

BCLI

Motley Fool

10 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

BCLI

Motley Fool

10 months ago

Better AI Stock: Palantir vs. Snowflake

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

BCLI

Motley Fool

10 months ago

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

BCLI

Motley Fool

10 months ago

BigBear.ai Stock: Buy, Sell, or Hold?

Indonesia's first Olympic gymnast encourages others to 'dream higher'

BCLI

AFP

10 months ago

Indonesia's first Olympic gymnast encourages others to 'dream higher'

Where Will CrowdStrike Stock Be in 1 Year?

BCLI

Motley Fool

10 months ago

Where Will CrowdStrike Stock Be in 1 Year?

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

BCLI

GuruFocus.com

10 months ago

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

BCLI

GuruFocus.com

10 months ago

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

BCLI

Simply Wall St.

10 months ago

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn

BCLI

PR Newswire

10 months ago

BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn

BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

BCLI

PR Newswire

a year ago

BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn

BCLI

PR Newswire

a year ago

BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn

BCLI

Zacks Small Cap Research

a year ago

BCLI: Receives SPA Agreement from FDA on Design of Phase 3b Trial of NurOwn™…

BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule

BCLI

PR Newswire

a year ago

BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule

BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS

BCLI

PR Newswire

a year ago

BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

BCLI

PR Newswire

a year ago

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

BrainStorm Cell Therapeutics to Provide Update on NurOwn Program

BCLI

PR Newswire

a year ago

BrainStorm Cell Therapeutics to Provide Update on NurOwn Program

BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update

BCLI

PR Newswire

a year ago

BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update

BCLI

Zacks Small Cap Research

a year ago

BCLI: Unveils Plans for Phase 3b Trial of NurOwn® in ALS…

BrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific Conference

BCLI

PR Newswire

a year ago

BrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific Conference

BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS

BCLI

PR Newswire

a year ago

BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS

BrainStorm Cell Therapeutics to Present at European Life Sciences CEO Forum

BCLI

PR Newswire

a year ago

BrainStorm Cell Therapeutics to Present at European Life Sciences CEO Forum

Nutriband CEO Publishes Letter to Shareholders

BCLI

ACCESSWIRE

a year ago

Nutriband CEO Publishes Letter to Shareholders

Getaround Secures $20 Million in Financing, Following Strong Q3 2023 Results

BCLI

Business Wire

a year ago

Getaround Secures $20 Million in Financing, Following Strong Q3 2023 Results

Mullen Announces Bollinger Motors Receives Vehicle Orders for 40 B4, Class 4 EV Trucks; Valued at Approximately $6 Million

BCLI

GlobeNewswire

a year ago

Mullen Announces Bollinger Motors Receives Vehicle Orders for 40 B4, Class 4 EV Trucks; Valued at Approximately $6 Million

Sidoti Events, LLC's Virtual January Micro-Cap Conference

BCLI

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

U.S. Global Investors Announces Share Buyback Numbers for December 2023; Provides an Update on Competitive Year-End Performance for Quant Gold ETF

BCLI

GlobeNewswire

a year ago

U.S. Global Investors Announces Share Buyback Numbers for December 2023; Provides an Update on Competitive Year-End Performance for Quant Gold ETF

ECD Auto Design Expects Organic Revenue Growth of Over 50% in 2024 with Continued GAAP Profitability

BCLI

GlobeNewswire

a year ago

ECD Auto Design Expects Organic Revenue Growth of Over 50% in 2024 with Continued GAAP Profitability

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

BCLI

Benzinga

a year ago

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

Harte Hanks Extends Line of Credit with Texas Capital Bank

BCLI

ACCESSWIRE

a year ago

Harte Hanks Extends Line of Credit with Texas Capital Bank

Safe Harbor Financial Originates $9 Million First Lien Secured Loan for Major, MSO-Operated Cultivation Facility in Denver, Colorado

BCLI

GlobeNewswire

a year ago

Safe Harbor Financial Originates $9 Million First Lien Secured Loan for Major, MSO-Operated Cultivation Facility in Denver, Colorado

$Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia$

BCLI

GlobeNewswire

a year ago

Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia

Bright Scholar Filed Annual Report on Form 20-F for Fiscal 2023

BCLI

PR Newswire

a year ago

Bright Scholar Filed Annual Report on Form 20-F for Fiscal 2023

Expion360 Announces Financing Commitments of up to $22.5 Million

BCLI

ACCESSWIRE

a year ago

Expion360 Announces Financing Commitments of up to $22.5 Million

Yoshitsu Co., Ltd Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

BCLI

GlobeNewswire

a year ago

Yoshitsu Co., Ltd Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

OLD POINT FINANCIAL CORPORATION ANNOUNCES RETIREMENT OF DR. ARTHUR D. GREENE FROM BOARD OF DIRECTORS

BCLI

PR Newswire

a year ago

OLD POINT FINANCIAL CORPORATION ANNOUNCES RETIREMENT OF DR. ARTHUR D. GREENE FROM BOARD OF DIRECTORS

BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments

BCLI

PR Newswire

a year ago

BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments

Are Options Traders Betting on a Big Move in Airgain (AIRG) Stock?

BCLI

Zacks

a year ago

Are Options Traders Betting on a Big Move in Airgain (AIRG) Stock?

BrainStorm Issues 2023 Letter to Shareholders

BCLI

PR Newswire

a year ago

BrainStorm Issues 2023 Letter to Shareholders

BCLI

InvestorPlace

a year ago

3 Growth Stocks That Can Double in 2024

S&W Seed Company Appoints Jeffrey Rona to Its Board of Directors

BCLI

PR Newswire

a year ago

S&W Seed Company Appoints Jeffrey Rona to Its Board of Directors

Expion360 Enters Home Energy Storage Market with All-in-One and Scalable Lithium-ion Battery Solutions

BCLI

ACCESSWIRE

a year ago

Expion360 Enters Home Energy Storage Market with All-in-One and Scalable Lithium-ion Battery Solutions

Good Times Restaurants Inc. (NASDAQ:GTIM) Q4 2023 Earnings Call Transcript

BCLI

Insider Monkey

a year ago

Good Times Restaurants Inc. (NASDAQ:GTIM) Q4 2023 Earnings Call Transcript

Linkage Global Inc Announces Pricing of $6,000,000 Initial Public Offering

BCLI

GlobeNewswire

a year ago

Linkage Global Inc Announces Pricing of $6,000,000 Initial Public Offering

enVVeno Medical Posts Company Highlights and Materials from 2023 VEITH Symposium

BCLI

ACCESSWIRE

a year ago

enVVeno Medical Posts Company Highlights and Materials from 2023 VEITH Symposium

BCLI

Investing.com

a year ago

Midday movers: Adobe, Moderna, and more

Mesa Air Group Announces Intent to File Form 12b-25 and Delay Its Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

BCLI

GlobeNewswire

a year ago

Mesa Air Group Announces Intent to File Form 12b-25 and Delay Its Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

Gold Resource Corporation Reports High Grade Drill Results at the Don David Gold Mine

BCLI

Business Wire

a year ago

Gold Resource Corporation Reports High Grade Drill Results at the Don David Gold Mine

BCLI

GlobeNewswire

a year ago

Brad Jacobs to Enter Building Products Distribution Industry

BCLI

Zacks Small Cap Research

a year ago

BCLI: FDA Meeting Provides Clear Path for Planned Phase 3b Trial of NurOwn

BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS

BCLI

PR Newswire

a year ago

BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS

XPO's Brad Jacobs talks SilverSun acquisition, equity growth

BCLI

Yahoo Finance Video

a year ago

XPO's Brad Jacobs talks SilverSun acquisition, equity growth

Precision Optics Enters into Production and Technology Licensing Agreement for Single-Use Cystoscopy Robotic Surgery Program

BCLI

PR Newswire

a year ago

Precision Optics Enters into Production and Technology Licensing Agreement for Single-Use Cystoscopy Robotic Surgery Program

Shareholders Will Probably Hold Off On Increasing Natural Alternatives International, Inc.'s (NASDAQ:NAII) CEO Compensation For The Time Being

BCLI

Simply Wall St.

a year ago

Shareholders Will Probably Hold Off On Increasing Natural Alternatives International, Inc.'s (NASDAQ:NAII) CEO Compensation For The Time Being

Under The Bonnet, Drilling Tools International's (NASDAQ:DTI) Returns Look Impressive

BCLI

Simply Wall St.

a year ago

Under The Bonnet, Drilling Tools International's (NASDAQ:DTI) Returns Look Impressive

Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

BCLI

GlobeNewswire

a year ago

Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

Great Lakes Dredge & Dock to Present at Sidoti December Small Cap Virtual Conference on Wednesday, December 6, 2023

BCLI

GlobeNewswire

a year ago

Great Lakes Dredge & Dock to Present at Sidoti December Small Cap Virtual Conference on Wednesday, December 6, 2023

3 Hot Penny Stocks to Buy in Q4 for Promising Potential

BCLI

InvestorPlace

a year ago

3 Hot Penny Stocks to Buy in Q4 for Promising Potential

BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS

BCLI

PR Newswire

a year ago

BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS

Garry Mauro Bought 9.9% More Shares In LifeVantage

BCLI

Simply Wall St.

a year ago

Garry Mauro Bought 9.9% More Shares In LifeVantage

BrainStorm Cell Therapeutics to Present at 6th Annual ALS Research Symposia

BCLI

PR Newswire

a year ago

BrainStorm Cell Therapeutics to Present at 6th Annual ALS Research Symposia

BCLI

Zacks Small Cap Research

a year ago

BCLI: Phase 3b Trial Details to be Discussed with FDA…

BCLI

Insider Monkey

a year ago

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript

BCLI

Business Wire

a year ago

Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum™ Grows

America's Biggest Wood Pellet Exporter Warns Its Future Is in Jeopardy; Stock Crashes

BCLI

The Wall Street Journal

a year ago

Latest Brainstorm Cell Therapeutics Inc. (BCLI) News on April 3, 2025

Share on Social Networks: